For the fourth consecutive time, Accenture is positioned as a Leader in the IDC MarketScape vendor assessment covering IT outsourcing (ITO) across the life sciences research and development (R&D) industry.
“Technology has moved from an enabler to a core and central element of life sciences research and development. We are working with our clients to define technology-enabled business strategies, implement new technology platforms, and provide scaled operations in multi-year arrangements”
The report, “IDC MarketScape: Worldwide Life Science R&D ITO Services 2021 Vendor Assessment” examines the current life sciences R&D ITO landscape, including industry and market trends, and compares 11 major vendors against criteria IDC views as most important for life sciences companies to consider when selecting a service provider.
Top iTechnology Business News: Overcoming the Pitfalls of Poor Corporate Intelligence What Security Teams Need to Get Ahead
The report recognizes Accenture’s expertise in “building agile, lean, and digitally enabled business models from early discovery through approval, launch, delivery, full commercialization, and patient services.”
The report also notes that INTIENT, Accenture’s Life Sciences cloud platform for the enablement of intelligent business processes in the discovery, development and commercialization of New Science, is key to delivering leading R&D ITO services, such as clinical trial operations.
“Accenture leverages new tech, such as AI, machine learning, robotic process automation, and advanced analytics and has strong relationships with cloud providers, as well as enterprise software leaders and niche players, which makes it a very strong service provider,” said Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology at IDC. “As a result, Accenture has helped 90% of Fortune 500 Life Science companies deliver improved outcomes to patients, which clearly makes it stand out as a leader.”
“Technology has moved from an enabler to a core and central element of life sciences research and development. We are working with our clients to define technology-enabled business strategies, implement new technology platforms, and provide scaled operations in multi-year arrangements,” said Tom Lehmann, who leads Life Sciences R&D at Accenture. “Our global team is focused on using technology to reshape and deliver the R&D essential to delivering new products and treatments to patients.”
Top iTechnology Networking News: Ordr Unveils Cybersecurity Innovations and Ransom-Aware Rapid Assessment Service to Expand Its Leadership In Connected Device Security
[To share your insights with us, please write to sghosh@martechseries.com]
